5 Aug 2026 Punjab Khabarnama Bureau : The Union Government has stepped up scrutiny of advertisements promoting GLP-1 weight-loss drugs, directing stricter monitoring of promotional claims to ensure they comply with existing drug and advertising regulations.
The move aims to prevent misleading marketing and ensure that consumers receive accurate information about prescription medicines.
Focus on Promotional Claims
Authorities are examining advertisements and promotional material related to GLP-1 drugs to ensure that companies do not make exaggerated or unverified claims about weight loss, safety or effectiveness.
Officials have emphasised that such medicines should be promoted responsibly and in accordance with regulatory guidelines.
Prescription Medicines Require Medical Supervision
GLP-1 receptor agonists are prescription medicines used for specific medical conditions and, in some cases, weight management under a doctor’s supervision.
Health experts caution that these medicines are not suitable for everyone and should only be used after proper medical evaluation.
Consumer Protection Priority
The government said stricter checks are intended to safeguard consumers from misleading advertisements that may encourage self-medication or unrealistic expectations.
Regulators are expected to take action against advertisements found to be in violation of applicable laws.
Responsible Advertising Encouraged
Officials have urged pharmaceutical companies and advertisers to ensure that all promotional content is factual, balanced and supported by scientific evidence.
Healthcare professionals continue to advise patients to consult qualified doctors before starting any weight-loss medication.